Many users are left to pay for GLP-1 weight loss medications, which can cost more than $1,000 per month, out of pocket
A comprehensive literature search was performed in PubMed, Web of Science, Embase, and Scopus from inception to October 2025 using the keywords tirzepatide, GLP-1/GIP receptor agonist, obstructive sleep apnea, and obesity. Priority was given to randomized controlled trials, major observational studies, and relevant mechanistic research
Some medications may be prepared by licensed 503A compounding pharmacies and are not FDA-approved
GLP-1, says Kunal Shah, MD, an assistant professor in the division of endocrinology at the Rutgers Robert Wood Johnson Medical Center